Research on oxidative stress focused primarily on determining how reactive oxygen species (ROS) damage cells by indiscriminate reactions with their macromolecular machinery, particularly lipids, proteins, and DNA. However, many chronic diseases are not always a consequence of tissue necrosis, DNA, or protein damage, but rather to altered gene expression. Gene expression is highly regulated by the coordination of cell signaling systems that maintain tissue homeostasis. Therefore, much research has shifted to the understanding of how ROS reversibly control gene expression through cell signaling mechanisms. However, most research has focused on redox regulation of signal transduction within a cell, but we introduce a more comprehensive-systems biology approach to understanding oxidative signaling that includes gap junctional intercellular communication, which plays a role in coordinating gene expression between cells of a tissue needed to maintain tissue homeostasis. We propose a hypothesis that gap junctions are critical in modulating the levels of second messengers, such as low molecular weight reactive oxygen, needed in the transduction of an external signal to the nucleus in the expression of genes. Thus, any comprehensive-systems biology approach to understanding oxidative signaling must also include gap junctions, in which aberrant gap junctions have been clearly implicated in many human diseases. Antioxid. Redox Signal. 11, 297-307.
297Oxidative Damage vs. Oxidative Signaling O XIDATIVE STRESS HAS LONG BEEN AFFILIATED with acute and chronic human diseases, and was believed to be primarily a consequence of indiscriminate, cumulative damage to proteins, lipids, and DNA from the vigorous production of reactive oxygen species (ROS) that overwhelm the cell's antioxidant defense system. However, pathological causes of many chronic diseases, particularly cancer, have also been linked with noncytotoxic nongenotoxic events, and the role of ROS and antioxidants in human diseases must also address epigenetic events (10,15,29,76,99).Oxygen was first implicated in cancer as far back as the 1920s by Otto Warburg (111). Initially his theory of altered oxidative metabolism fell mostly on deaf ears. However, recently there has been a renewed interest in how cancer cells shift their energy production from oxidative phosphorylation to anaerobic glycolysis, the "Warburg Effect," that is now considered a fundamental property of cancer cells and not just a consequence of malignant cell transformation (3,54,116). In contrast to this role of low oxygen tensions in cancer, the discovery of superoxide dismutase in 1968 by McCord and Fridovich (70) led to an explosion of research on the role of reactive oxygen, a product of high oxygen tensions, in the pathologies of biological organisms, and has been specifically connected with not only cancer but also many other human diseases (1, 41). For many years, research in oxidative stress at high oxygen tensions focused primarily on determining the mechanisms by which ROS damage cel...